In today's data-rich environment, business are always looking for a way to capitalize on available data for new insights and ...

The Florida Gators just had their first winning season, but the sky is the limit for head coach Billy Napier as he enters year four in Gainesville. Napier returns plenty of talent on both sides of the ...

Artificial intelligence-native data insights startup Wisdom AI Inc. is expanding its platform today with the launch of Proactive Agents. The agents act like automated data analysts and work around the ...

Google has agreed to pay $30 million to settle a long-running lawsuit by parents and their children claiming its YouTube video app collected data from millions of U.S. kids under 13 so it could target ...

During a recent Senate hearing, Secretary of State Marco Rubio got into a heated exchange with Senator Tim Kaine (D-VA), who grilled him over the Trump Administration giving preferential treatment to ...

Zach Calzada’s college journey has stretched across the SEC, the FCS and back again, and now he will take on a new challenge in Lexington. ESPN’s Pete Thamel reported that the Kentucky Wildcats have ...

More than 55 million visa holders are now under continuous vetting as the Trump administration intensifies its immigration crackdown. The State Department first confirmed the move to The Associated ...

Verily, Google's life sciences sister company, has laid off staff and cut its devices program. In a memo to staff, CEO Stephen Gillett said Verily was continuing to narrow its focus. "The path forward ...

The last time I spoke about Biohaven (BHVN) it was with respect to a Seeking Alpha article entitled "Biohaven: Positive SCA Treatment Data Leads To Q4 of 2024 NDS Submission Catalyst." In this article ...

Missouri will be the first SEC team to hit the field in the 2025 season when the Tigers take on Central Arkansas on Thursday night. The contest kicks off a 16-game slate of non-conference play during ...

Milan, Italy, September 5, 2025 – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases ...